This inventor holds 4 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignee: Eisai R&d Management Co., Ltd.. Active years: 2021-2023.
Company Filing History:
Years Active: 2021-2023
Title: Mai Miyamoto: Innovator in Dementia Therapeutics
Introduction
Mai Miyamoto is a prominent inventor based in Tsukuba, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents for dementia. With a total of 4 patents to her name, her work is paving the way for innovative treatments in this critical area of healthcare.
Latest Patents
Miyamoto's latest patents include a therapeutic agent for Alzheimer's disease and Lewy body dementia. This agent combines a pyrazoloquinoline derivative with donepezil, providing a promising approach to treatment. Another notable patent involves a pharmaceutical composition comprising a PDE9 inhibitor, which is crucial for advancing therapeutic options in dementia care.
Career Highlights
Mai Miyamoto is currently associated with Eisai R&D Management Co., Ltd., where she continues to push the boundaries of pharmaceutical research. Her work is characterized by a commitment to improving the lives of those affected by dementia through innovative solutions.
Collaborations
Miyamoto collaborates with esteemed colleagues such as Sadaharu Kotani and Edgar Schuck, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Mai Miyamoto's contributions to dementia therapeutics exemplify the impact of dedicated inventors in the pharmaceutical industry. Her innovative patents and collaborative efforts are vital in the ongoing fight against dementia.